Omics Lab Services Market Report 2025

The omics lab services market size has grown rapidly in recent years. It will grow from $94.52 billion in 2024 to $109.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period is attributed to increasing government funding, expansion of personalized medicine, high prevalence of chronic diseases, growth of precision oncology, and the rise of biotechnology and pharmaceutical industries.

The omics lab services market size is expected to see rapid growth in the next few years. It will grow to $194.52 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to the rise in companion diagnostics, increasing use of liquid biopsies, globalization of clinical trials, increasing prevalence of chronic diseases, and increasing investments in biotechnology. Major trends in the forecast period include rapid technological advancements, development of the products for human genome sequencing, integration of cloud analytics and big‑data platforms, multi‑omics integration, and collaborations between pharmaceutical companies.

The growing prevalence of genetic diseases is expected to drive the expansion of the omics lab services market. Genetic diseases, caused by mutations or abnormalities in an individual's DNA, can be inherited or occur spontaneously. Their increasing diagnosis is largely due to advancements in technologies such as next-generation sequencing and other genomic tools, which have improved the ability to identify previously undetected or misclassified conditions. Omics lab services play a critical role in analyzing complex biological data to detect genetic mutations and molecular changes, enabling earlier diagnosis and more personalized treatment approaches. For example, in October 2024, the Cystic Fibrosis Trust reported that 11,318 individuals were registered with cystic fibrosis in 2023, up from 11,148 in 2022, marking a 1.5% year-over-year increase. This trend reflects a growing demand for omics-based diagnostics and is contributing to the market’s growth.

Key players in the omics lab services market are introducing innovative omics analysis solutions to support personalized medicine and enable integrated multi-omics research. These services involve large-scale analysis of genes, RNA, proteins, metabolites, and epigenetic factors to better understand biological systems and support a range of healthcare applications. In May 2022, Bertis Inc., a biotechnology company based in South Korea, launched the Pan-omics Analysis Service & Solution (PASS), a platform that integrates mass spectrometry-based proteomics with proprietary bioinformatics and artificial intelligence. PASS supports clinical research and drug development through services such as protein identification, biomarker discovery, and data analytics. This launch marked Bertis’s strategic shift from diagnostics to advanced omics analysis, providing deeper insights into disease mechanisms and helping advance personalized medicine.

In July 2024, Anacura, a healthcare and life sciences company based in Belgium, acquired ohmX.bio NV for an undisclosed sum. This acquisition aims to enhance Anacura’s capabilities in advanced multi-omics, supporting faster drug discovery and diagnostic development. It also reinforces Anacura’s position as a comprehensive service provider within the Ghent biotech hub and the broader life sciences sector. ohmX.bio NV, also based in Belgium, specializes in omics solutions across genomics, transcriptomics, and epigenomics, strengthening Anacura’s expertise in integrated omics research.

Major players in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics.

North America was the largest region in the omics lab services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the Omics Lab Services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Omics lab services refer to a comprehensive suite of laboratory offerings focused on analyzing the full range of biological molecules within a biological system. These services aim to provide a holistic understanding of how molecular components are structured, regulated, and interact to influence the function and organization of living organisms.

The primary types of services in omics lab services include genomics, transcriptomics, proteomics, metabolomics, and epigenomics. Genomics involves the study of an organism’s complete DNA set, including all genes and their functions. These services are delivered through models such as contract services, in-house services, consultative services, collaborative research, and custom solutions, utilizing technologies such as next-generation sequencing (NGS), microarray analysis, mass spectrometry, chromatography, and bioinformatics tools. Applications span drug discovery, diagnostics, personalized medicine, and more. Key end-users include research institutions, pharmaceutical and biotechnology companies, academic institutions, and clinical laboratories.

The omics lab services market research report is one of a series of new reports that provides omics lab services market statistics, including omics lab services industry global market size, regional shares, competitors with an omics lab services market share, detailed omics lab services market segments, market trends and opportunities, and any further data you may need to thrive in the omics lab services industry. This omics lab services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The omics lab services market includes revenues earned by entities by providing services such as whole genome sequencing, expression profiling, protein identification, biomarker discovery, and chromatin immunoprecipitation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.